Changchun High & New Technology Industries Group Inc - Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc (000661) has an Asset Resilience Ratio of 5.50% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000661 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1996–2025)
This chart shows how Changchun High & New Technology Industries Group Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Changchun High & New Technology Industri balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Changchun High & New Technology Industries Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 000661 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.69 Billion | 5.5% |
| Total Liquid Assets | CN¥1.69 Billion | 5.50% |
Asset Resilience Insights
- Limited Liquidity: Changchun High & New Technology Industries Group Inc maintains only 5.50% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Changchun High & New Technology Industries Group Inc Industry Peers by Asset Resilience Ratio
Compare Changchun High & New Technology Industries Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for Changchun High & New Technology Industries Group Inc (1996–2025)
The table below shows the annual Asset Resilience Ratio data for Changchun High & New Technology Industries Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.76% | CN¥1.43 Billion ≈ $209.35 Million |
CN¥30.08 Billion ≈ $4.40 Billion |
+4.68pp |
| 2024-12-31 | 0.08% | CN¥24.96 Million ≈ $3.65 Million |
CN¥31.05 Billion ≈ $4.54 Billion |
+0.05pp |
| 2023-12-31 | 0.03% | CN¥9.96 Million ≈ $1.46 Million |
CN¥30.74 Billion ≈ $4.50 Billion |
+0.39pp |
| 2022-12-31 | -0.36% | CN¥-93.39 Million ≈ $-13.67 Million |
CN¥26.03 Billion ≈ $3.81 Billion |
+0.22pp |
| 2021-12-31 | -0.57% | CN¥-129.31 Million ≈ $-18.92 Million |
CN¥22.52 Billion ≈ $3.29 Billion |
-0.64pp |
| 2020-12-31 | 0.06% | CN¥10.28 Million ≈ $1.50 Million |
CN¥16.91 Billion ≈ $2.47 Billion |
-1.64pp |
| 2019-12-31 | 1.70% | CN¥215.86 Million ≈ $31.59 Million |
CN¥12.72 Billion ≈ $1.86 Billion |
-4.72pp |
| 2018-12-31 | 6.41% | CN¥605.00 Million ≈ $88.53 Million |
CN¥9.43 Billion ≈ $1.38 Billion |
-6.78pp |
| 2017-12-31 | 13.19% | CN¥970.00 Million ≈ $141.94 Million |
CN¥7.35 Billion ≈ $1.08 Billion |
-10.82pp |
| 2016-12-31 | 24.02% | CN¥1.49 Billion ≈ $218.03 Million |
CN¥6.20 Billion ≈ $907.77 Million |
+25.43pp |
| 2015-12-31 | -1.41% | CN¥-53.95 Million ≈ $-7.89 Million |
CN¥3.82 Billion ≈ $558.33 Million |
-1.42pp |
| 2014-12-31 | 0.01% | CN¥179.55K ≈ $26.27K |
CN¥3.15 Billion ≈ $460.71 Million |
+4.31pp |
| 2008-12-31 | -4.30% | CN¥-66.57 Million ≈ $-9.74 Million |
CN¥1.55 Billion ≈ $226.45 Million |
+0.75pp |
| 2007-12-31 | -5.05% | CN¥-76.39 Million ≈ $-11.18 Million |
CN¥1.51 Billion ≈ $221.22 Million |
-5.07pp |
| 2005-12-31 | 0.02% | CN¥300.00K ≈ $43.90K |
CN¥1.41 Billion ≈ $206.88 Million |
0.00pp |
| 2004-12-31 | 0.02% | CN¥300.00K ≈ $43.90K |
CN¥1.39 Billion ≈ $203.99 Million |
+0.00pp |
| 2003-12-31 | 0.02% | CN¥300.00K ≈ $43.90K |
CN¥1.55 Billion ≈ $226.98 Million |
-0.01pp |
| 2002-12-31 | 0.02% | CN¥300.00K ≈ $43.90K |
CN¥1.22 Billion ≈ $178.72 Million |
+0.02pp |
| 1998-12-31 | 0.01% | CN¥87.65K ≈ $12.83K |
CN¥1.30 Billion ≈ $190.46 Million |
-0.54pp |
| 1996-12-31 | 0.54% | CN¥4.00 Million ≈ $584.70K |
CN¥737.35 Million ≈ $107.90 Million |
-- |
About Changchun High & New Technology Industries Group Inc
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasa… Read more